HAP

12.07.2010 - Alterada decisão liminar para dispensação de bosentana para o tratamento da HAP

This article has no translation available.
   

Pulmonary Arterial Hypertension (PAH)

Sought by the associations of patients with pulmonary arterial hypertension (PAH), ISPhar sought entry into the public civil action brought by federal prosecutors in the face of the Union, to compel it to include bosentan and sildenafil in the medication lists for treatment of PAH. The judge granted the injunction, but the Ministry of Health only included bosentan in the lists of treatment, failing to comply the judicial determination.

This is a translated summary of original news in portuguese.

Click here to read the original news

   

1. Patologia

This article has no translation available.

Read more: 1. Patologia

   

2. Classificação

This article has no translation available.

Read more: 2. Classificação

   

3. Incidência

This article has no translation available.

Read more: 3. Incidência

   

4. Tratamento farmacológico da HAP

This article has no translation available.

Read more: 4. Tratamento farmacológico da HAP

   

5. Acesso ao tratamento

This article has no translation available.

Read more: 5. Acesso ao tratamento

   

Referências Bibliográficas

This article has no translation available.